Micardis (telmisartan)

Micardis is a well-known prescription medication used primarily to treat high blood pressure (hypertension) and to reduce the risk of cardiovascular events such as heart attacks or strokes. The active ingredient, telmisartan, belongs to a class of drugs called angiotensin II receptor blockers (ARBs).

The brand was developed and launched by the German pharmaceutical giant Boehringer Ingelheim. Since its approval in the late 1990s, it has become a staple in cardiovascular medicine worldwide. While the brand is German in origin, manufacturing is distributed across the company's global network of production facilities to meet regional market demands and regulatory requirements.

Boehringer Ingelheim remains the ultimate owner of the brand. As one of the world's largest private pharmaceutical companies, it maintains a strong focus on research and development in respiratory, cardiovascular, and metabolic diseases. In some territories, the brand may be distributed through local subsidiaries or via marketing partnerships with other pharmaceutical entities.